Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis
- 3 July 2009
- journal article
- Published by Elsevier BV in Experimental and Molecular Pathology
- Vol. 87 (2), 99-104
- https://doi.org/10.1016/j.yexmp.2009.06.003
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell linesBlood, 2008
- The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivoJournal of Cellular and Molecular Medicine, 2008
- The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?Cellular and Molecular Life Sciences, 2007
- FOXP3 ensembles in T‐cell regulationImmunological Reviews, 2006
- Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis.Epigenetics, 2006
- Resetting the Epigenetic Histone Code in the MRL-lpr/lpr Mouse Model of Lupus by Histone Deacetylase InhibitionJournal of Proteome Research, 2005
- Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107Proceedings of the National Academy of Sciences of the United States of America, 2005
- The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cellsArthritis Research & Therapy, 2005
- A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritisMolecular Therapy, 2003
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003